SOPH (Sophia Genetics) ROCE % : -41.07% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sophia Genetics's annualized ROCE % for the quarter that ended in Sep. 2024 was -41.07%.

Sophia Genetics ROCE % Historical Data

The historical data trend for Sophia Genetics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics ROCE % Chart

Sophia Genetics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-66.90

-56.51

-36.23

-34.19

-40.20

Sophia Genetics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-35.90	-50.71	-46.80	-39.68	-41.07

Sophia Genetics ROCE % Calculation

Sophia Genetics's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-77.907	/	( ( (243.838 - 26.81)	+	(206.156 - 35.621) )	/ 2 )
	=	-77.907	/	( (217.028	+	170.535)	/ 2 )
	=	-77.907	/	193.7815
	=	-40.20 %

Sophia Genetics's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-61.452	/	( ( (181.096 - 28.609)	+	(177.608 - 30.86) )	/ 2 )
	=	-61.452	/	( ( 152.487	+	146.748 )	/ 2 )
	=	-61.452	/	149.6175
	=	-41.07 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Sophia Genetics (NAS:SOPH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sophia Genetics ROCE % Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sophia Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

90B:Germany

Address

La Pièce 12, Rolle, CHE, CH-1180

Website

https://www.sophiagenetics.com

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.